Acute Kidney Injury in Critical Care
Acute kidney injury (AKI) is an abrupt decline in kidney function, defined by a rise in serum creatinine and/or a fall in urine output over hours to days. It is one of the most frequent organ complications in the intensive care unit, where it usually arises in the setting of sepsis, shock, major surgery, or nephrotoxic exposure, and where it independently marks a higher risk of death and of later chronic kidney disease.
Definition
Acute kidney injury is an abrupt (within 7 days) reduction in kidney function, identified by an increase in serum creatinine of at least 0.3 mg/dL within 48 hours or to at least 1.5 times baseline, or by a sustained reduction in urine output, and graded into three stages of increasing severity by the KDIGO criteria.
Scope
This topic covers the definition and staging of AKI, its principal causes and mechanisms in critically ill patients, the consensus criteria used to recognise it, and its prognostic and epidemiologic importance. It is a reference-educational entry describing how AKI is conceptualised and classified; it does not provide management protocols, fluid orders, or drug dosing.
Key concepts
- KDIGO staging of AKI
- Serum creatinine and urine output criteria
- Pre-renal, intrinsic (acute tubular necrosis), and post-renal causes
- Sepsis-associated AKI
- AKI to chronic kidney disease transition
- Biomarkers of tubular injury
- RIFLE and AKIN antecedent definitions
Mechanisms
AKI in the critically ill most often reflects a combination of reduced renal perfusion, systemic inflammation, and microcirculatory and tubular injury. Classically the causes are grouped as pre-renal (hypoperfusion from hypovolaemia or shock), intrinsic (acute tubular necrosis, nephrotoxic or ischaemic), and post-renal (obstruction). In sepsis, haemodynamic, inflammatory, and metabolic mechanisms act together rather than a single ischaemic insult. Because creatinine rises only after function has already fallen, the functional definitions capture injury with a delay, which has motivated interest in earlier biomarkers of tubular stress. Even when kidney function recovers, an episode of AKI can leave residual damage that predisposes to chronic kidney disease.
Clinical relevance
Recognising and staging AKI is fundamental to critical care because the syndrome is common, affects fluid, electrolyte, and drug handling, and signals a worse prognosis. This entry explains how AKI is defined and staged for the purpose of evidence appraisal and education; decisions about an individual patient's diagnosis, fluids, or therapy rest with the treating team and are outside its scope.
Epidemiology
AKI is identified in a large proportion of intensive care unit admissions when consensus criteria are applied, and a meaningful minority of affected patients progress to severe stages or require renal replacement therapy. Sepsis is the leading contributing factor in critically ill cohorts, and survivors of severe AKI carry an elevated long-term risk of chronic kidney disease and mortality.
History
Historically termed acute renal failure, the syndrome long lacked a uniform definition, which hampered comparison across studies. The RIFLE criteria (2004) and the AKIN modification (2007) introduced graded, consensus definitions, and these were harmonised into the KDIGO criteria in 2012, which now anchor diagnosis, staging, and epidemiology. The renaming to acute kidney injury reflected recognition that lesser degrees of injury, short of overt failure, also carry prognostic weight.
Debates
- Is serum creatinine an adequate marker of acute kidney injury?
- Creatinine rises late and is influenced by muscle mass, dilution, and tubular secretion, so it detects injury with delay; whether novel tubular-injury biomarkers should supplement or replace functional criteria for earlier recognition remains an active question.
Key figures
- John Kellum
- Joseph Bonventre
- Lakhmir Chawla
- Rinaldo Bellomo
Related topics
Seminal works
- kdigo-2012
- thadhani-1996
- chawla-2014
Frequently asked questions
- How is acute kidney injury defined in critical care?
- By the KDIGO criteria: a rise in serum creatinine of at least 0.3 mg/dL within 48 hours or to at least 1.5 times baseline within 7 days, or a sustained drop in urine output, with severity graded into three stages.
- Why does AKI matter beyond the acute episode?
- Even when kidney function appears to recover, an episode of AKI is associated with a higher long-term risk of chronic kidney disease and death, which is why AKI and CKD are described as interconnected syndromes.